Natamycin Suppliers & Bulk Manufacturers
Available Forms: Ophthalmic Solution
Available Strengths: 5%
Reference Brands: Natacyn (USA/EU)
Category:
Anti-fungal
Natamycin is available in Ophthalmic Solution
and strengths such as 5%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Natamycin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Natamycin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Natamycin, also known as pimaricin, is a topical antifungal medication used primarily to treat fungal infections around the eye. It is effective against infections of the eyelids, conjunctiva, and cornea and is commonly administered as eyedrops. Natamycin belongs to the macrolide and polyene families of medications and works by disrupting the fungal cell membrane, leading to fungal cell death. This targeted mechanism makes it highly effective against a wide range of ocular fungal pathogens.
In addition to its medical use, natamycin is employed in the food industry as a preservative to prevent fungal growth in various products. While generally well tolerated, allergic reactions may occur, and its safety during pregnancy or breastfeeding has not been fully established.
Natamycin was first discovered in 1955 and approved for medical use in the United States in 1978. It is listed on the World Health Organization’s List of Essential Medicines due to its importance in treating serious fungal infections. Natamycin is produced through fermentation of specific strains of the bacterium Streptomyces, ensuring a reliable and consistent supply for medical and industrial applications.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing